National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

anti-CD70 monoclonal antibody MDX-1411
A glycoengineered, fully humanized IgG1 monoclonal antibody directed against the extracellular domain of the human CD70 molecule with potential antineoplastic activity. Anti-CD70 fully human monoclonal antibody MDX-1411 selectivity binds to the extracellular domain of CD70, which may induce an antibody-dependent cellular cytotoxicity (ADCC) response against CD70-expressing tumor cells. CD70, the ligand for the costimulatory receptor CD27 and a member of the tumor necrosis factor (TNF) family, is found on renal cell carcinoma (RCC) cells among other cancer cell types. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:MDX-1411



Previous:anti-CD33 monoclonal antibody-DM4 conjugate AVE9633, anti-CD37 single-chain polypeptide TRU-016, anti-CD38 monoclonal antibody, anti-CD45 monoclonal antibody, anti-CD45 monoclonal antibody AHN-12
Next:anti-CEA IgCD28TCR-transduced autologous T cells, anti-CEA/anti-DTPA-In (F6-734) bispecific antibody, anti-CS1 monoclonal antibody HuLuc63, anti-denatured collagen recombinant monoclonal antibody TRC093, anti-DR5 agonist monoclonal antibody TRA-8

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov